A clinical trial to compare two procedures for acne scars on face - microdermabrasion and Er:YAG laser

Efficacy and safety of Er:YAG laser in comparison with microdermabrasion in facial acne scarring: A randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/09/007235

Enrollment

102

Registered

2016-09-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- facial acne scars

Interventions

Intervention1: Microdermabrasion: Microdermabrasion 4-6 sittings Control Intervention1: Er:YAG laser: Er:YAG laser 4-6 sittings

Eligibility

Inclusion criteria

Inclusion criteria: Adult males or females with atrophic acne scars of grades 2,3 and 4

Exclusion criteria

Exclusion criteria: • Age less than 12 years and greater than 60 years. • Pregnant and lactating women. • Active acne. • Coexisting inflammation in adjacent skin secondary to dermatological diseases such as psoriasis, lichen planus, eczemas, acne. • Keloidal tendency. • On isotretinoin for last 6 months to 1 year. • Patients with unrealistic expectations or psychiatric illnesses. • Preexisting bleeding disorder, renal or hepatic diseases.

Design outcomes

Primary

Measure	Time frame
clinical improvement in facial acne scars between two groups (Microdermabrasion, Er:YAG)Timepoint: 1 year	—

Secondary

Measure	Time frame
side effects, change in quality of life between two groupsTimepoint: 1 year	—

Countries

India

Contacts

Public ContactRashmi kumari

Jawaharlal Institute of Postgraduate Medical Education and Research

rashmi.sreerag@gmail.com09489692199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026